2. Anti-infection
  3. SARS-CoV
  4. SARS-CoV-2-IN-34

SARS-CoV-2-IN-34 (S-20-1) 是一种具有广谱抑制活性的，可穿透血脑屏障的 pan-coronavirus (CoV) fusion 抑制剂。SARS-CoV-2-IN-34 有效抑制伪型和真型 SARS-CoV-2 和其伪型变体 (VOCs) 的感染效应。SARS-CoV-2-IN-34 对 SARS-CoV-2 S1 和 S2 蛋白的 HR1 和 RBD 结构域具有高度亲和性。SARS-CoV-2-IN-34 可用于感染的研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Custom Peptide Synthesis

SARS-CoV-2-IN-34 Chemical Structure

SARS-CoV-2-IN-34 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

SARS-CoV-2-IN-34 相关抗体

Top Publications Citing Use of Products

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

SARS-CoV-2-IN-34 (S-20-1) is a blood brain barrier penetrable pan-coronavirus (CoV) fusion inhibitor with broad-spectrum inhibitory activity. SARS-CoV-2-IN-34 effectively inhibits infection by pseudotyped and authentic SARS-CoV-2, and pseudotyped variants of concern (VOCs). SARS-CoV-2-IN-34 shows high affinity to RBD in S1 and HR1 domain in S2 of SARS-CoV-2 S protein. SARS-CoV-2-IN-34 can be used for the research of infection[1].

体外研究
(In Vitro)

SARS-CoV-2-IN-34 (0.1-100 μM; 30 min) inhibits infection by PsV of SARS variants on Huh-7 and Caco-2 cells with IC50s values ranging from 0.54 to 10.23 μM and inhibits infection of pseudotyped SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, and bat SARSr-CoV WIV1 with IC50s ranging from 1.30 to 12.02 μM[1].
SARS-CoV-2-IN-34 (0.1-100 μM; 30 min) inhibits the replication of authentic SARS-CoV 2 on Caco-2 cell line with an IC50 value of 8.14 μM and inhibits authentic HCoV-OC43 and HCoV-229E infection in RD cells and Huh-7 cells with IC50s of 6.25 and 9.46 μM, respectively[1].
SARS-CoV-2-IN-34 (0.1-100 μM; 2-4 h) potently inhibits cell-cell fusion mediated by S protein of SARS-CoV-2, SARS-CoV, MERS CoV, HCoV-229E and HCoV-NL63 with IC50s ranging from 1.47 to 5.44 μM[1].
SARS-CoV-2-IN-34 (50 μM; 1 h) inhibits SARS-CoV-2 infection at the early stage of viral entry[1].
SARS-CoV-2-IN-34 (0-2 μM) shows binding effects to S1, RBD and HR with Kd value of 67, 61 and 277 nM, respectively[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

SARS-CoV-2-IN-34 相关抗体:

Cell Cytotoxicity Assay[1]

Cell Line: Huh-7, Caco-2 and RD cell lines
Concentration: 0-1000 μM
Incubation Time: 12 hours
Result: Showed low on Huh-7, Caco-2 and RD cells with CC50s of ＞800, 692.7 and 274.2 μM, respectively.
体内研究
(In Vivo)

SARS-CoV-2-IN-34 (60 and 80 mg/kg; intranasal route 0.5 h pre- or post-challenge with HCoV-OC43 and SARS-CoV-2 Delta) effectively protects mice from infection[1].
SARS-CoV-2-IN-34 (50 mg/kg; i.p. and p.o. once ) shows good oral bioavailability and higher absorption rate under fed conditionsis, it is expected to have potential oral bioavailability[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 mice with HCoV-OC43 infection[1]
Dosage: 80 mg/kg
Administration: Intranasal route; 80 mg/kg 0.5 h pre- or post-challenge with HCoV-OC43
Result: Significantly decreased relative HCoV-OC43 RNA level of both prevention and treatment group.
Animal Model: hACE2-transgenic C57BL/6 mice with SARS-CoV-2 Delta variant infection[1].
Dosage: 60 mg/kg
Administration: Intranasal route; 60 mg/kg 0.5 h pre- or post-challenge with SARS-CoV-2 Delta
Result: Exhibited prophylactic and therapeutic effect against SARS-CoV-2 Delta infection with intranasally administered.
分子量

1683.06

Formula

C91H119N13O16S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

SARS-CoV-2-IN-34 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

SARS-CoV-2-IN-34SARS-CoVSARS coronaviruscyclicγ-AApeptidelong-actingpseudotyped variantsinfectionHR1RBDInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
SARS-CoV-2-IN-34
目录号：
HY-P3492
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z